Canaccord Adams Raises Price Target On Inverness Medical (IMA) to $49, Citing Pima System
Tweet Send to a Friend
Canaccord Adams lifted their price target on Inverness Medical Innovations Inc. (NYSE: IMA) from $40 to $49, reiterating their Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
